Bayer response to lice study
This article was originally published in The Tan Sheet
Executive Summary
Conclusions on efficacy of Rid pediculicide cannot be drawn from recent in vitro study because University of Miami researchers "completely ignored" directions for use, Bayer says. Study in February Archives of Dermatology reported on kill rates of head lice exposed to cotton disks impregnated with OTC, Rx pediculicides (1"The Tan Sheet" March 4, 2002, p. 10). "Contrary to the method used in the study, Rid must be applied twice in a 10-day period, followed by combing on each occasion," Bayer says. "During each application lice are completely covered with Rid. The technique of placing lice on filter paper soaked with Rid, used in this study, would not be effective"...
You may also be interested in...
Pediculicide Formulation, Vehicle Differences Cited In Efficacy Study
The "large difference of efficacy" between two OTC pyrethrin products in a recent study is due to formulation and vehicle disparities in the lice remedies, researchers say in the February Archives of Dermatology
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.